ArticleDermatology and therapy2026

D-CARE (Delgocitinib-Chronic hAnd Eczema Response Evaluation): A Retrospective, Multicenter, Real-World Study of Patients with Chronic Hand Eczema (CHE) Treated with Delgocitinib 2% Cream-Temporal Analysis of Symptom and Clinical Sign Response.

Maddalena Napolitano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.